Under construction – not a live service
Sign in
Taking people in ChinaNo phase

AI Analysis of Heart Sounds and ECG From a Wearable Patch for Heart Failure

Tests an AI tool using a wearable patch in adults with heart failure.

Plain-language title generated from the registry record
Registry title: Artificial Intelligence (AI) Analysis of Synchronized Phonocardiography (PCG) and Electrocardiogram(ECG)

Key facts

Where
Shanghai, ChinaSee the 3 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Source: NCT06009718, who can take part

Where in China

  • Ruijin Hospital, Shanghai Jiaotong School of MedicineShanghai, ChinaTaking people
  • Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine,Shanghai, ChinaTaking people
  • Shanghai East HospitalShanghai, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Ruijin Hospital
Trial code
NCT06009718
Record updated
16 January 2025
Original description
The diagnosis of depressed left ventricular ejection fraction (dLVEF) (EF<50%) depends on golden standard ultrasound cardiography (UCG). A wearable synchronized phonocardiography (PCG) and electrocardiogram (ECG) device can assist in the diagnosis of dLVEF, which can both expedite access to life-saving therapies and reduce the need for costly testing.Read full original descriptionShow less

A Deep-learning-based Multi-modal Phonocardiogram(PCG) and Electrocardiogram(ECG) Processing Framework for Screening Depressed Left Ventricular Ejection Fraction (dLVEF) Using a Wearable Cardiac Patch

The diagnosis of depressed left ventricular ejection fraction (dLVEF) (EF<50%) depends on golden standard ultrasound cardiography (UCG). A wearable synchronized phonocardiography (PCG) and electrocardiogram (ECG) device can assist in the diagnosis of dLVEF, which can both expedite access to life-saving therapies and reduce the need for costly testing.

Inclusion: Attendance at RuiJin hospital for UCG; Signed dated informed consent; Commit to follow the research procedures and cooperate in the implementation of the whole process research; UCG has been completed; Age ≥ 18; At least 8 consecutive cycles of sinus rhythm can be recorded.

Exclusion: Left chest skin damaged or allergic to patch; Patients with pacemakers; Complete left bundle branch block or block or QRS wave widening>120ms; Refusal to participate.

ClinicalTrials.gov NCT06009718